LVDD

Clinical trials for LVDD explained in plain language.

Never miss a new study

Get alerted when new LVDD trials appear

Sign up with your email to follow new studies for LVDD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New triple therapy aims to reverse heart damage in stiff heart condition

Disease control Recruiting now

This study tests whether a combination of three heart medications (SGLT2 inhibitor, ARNI, and MRA) can improve heart structure, function, and daily life in people with advanced heart failure with preserved ejection fraction (HFpEF). Fifty participants will receive either the trip…

Matched conditions: LVDD

Phase: PHASE2 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control

Last updated May 17, 2026 05:05 UTC

LVDD

Get alerted when new LVDD trials appear

New triple therapy aims to reverse heart damage in stiff heart condition